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ABSTRACT
In vivo, enzymatic reduction of some protein disulﬁde bonds, allosteric disulﬁde bonds, provides an
important level of structural and functional regulation. The free cysteine residues generated can be
labeled by maleimide reagents, including biotin derivatives, allowing the reduced protein to be detected
or puriﬁed. During the screening of monoclonal antibodies for those speciﬁc for the reduced forms of
proteins, we isolated OX133, a unique antibody that recognizes polypeptide resident, N-ethylmaleimide
(NEM)-modiﬁed cysteine residues in a sequence-independent manner. OX133 offers an alternative to
biotin-maleimide reagents for labeling reduced/alkylated antigens and capturing reduced/alkylated
proteins with the advantage that NEM-modiﬁed proteins are more easily detected in mass spectrometry,
and may be more easily recovered than is the case following capture with biotin based reagents.
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Introduction
Disulﬁde bonds are generated during protein transport in the
endoplasmic reticulum (ER). They have long been regarded as
protein post-translational modiﬁcations that are important for
maintaining protein structure and function, but that rarely
change post-biosynthesis. Increasing evidence suggests, how-
ever, that changes in the cellular redox environment are used to
modify certain disulﬁde bonds at the cell surface, unmasking
protein function. These disulﬁde bonds, termed labile or allo-
steric bonds, are found in a wide variety of proteins, including
those in the extracellular environment and at the cell surface,1-4
where they have been shown to play a role in the activation of
immune cells,5 platelets,6 virus entry 7 and oncogene function.8
Cleavage of allosteric disulﬁde bonds on the cell surface
results from the sequestration to the cell surface of members of
the protein disulﬁde isomerase (PDI) family from the ER where
they act as reductants, rather than the oxidant and isomerase
activity when ER resident. For example, platelet activation,
which utilizes allosteric disulﬁde bonds to initiate thrombus
formation, is inhibited by antibodies to PDI,9,10 ERp5 11 or
ERp57.12 Similarly, inhibition of PDI, using antibodies or thiol-
blocking agents, prevents reduction of allosteric disulﬁde bonds
of the HIV envelope protein and inhibits entry of the virus into
cells. Accordingly, mapping the changes in disulﬁde bonding
patterns in cell surface proteins is crucial to understanding
redox-based control of protein function in normal and patho-
logical states. Using a differential labeling approach in which
resident free thiols were ﬁrst alkylated with methyl-PEO12–
maleimide and newly-labile disulﬁdes labeled with maleimide-
PEO2-biotin followed by avidin afﬁnity chromatography and
mass spectrometry (MS), Metcalfe et al, identiﬁed 87 candidate
proteins with labile disulﬁde bonds on the surface of the
murine 2B4 T-cell hybridoma line.13 A large range of activatory
and inhibitory receptors were found among those proteins con-
taining redox-labile/redox isomerase sensitive disulﬁde bonds,
including integrin adhesion receptors a6, aL, aV, b1, b2 and
b3 subunits, T-cell receptor chains, cytokine receptors and
members of the CD2/SLAM family of immune-signaling recep-
tors such as CD2, CD150, CD229 and CD244. These data,
along with bioinformatics-based analysis of protein structure,2-
4,14 indicate that labile disulﬁde bonds are present in many cell-
surface proteins and represent an under-investigated area of
understanding in the control of cellular function. However, a
signiﬁcant drawback to the identiﬁcation methods that rely on
cysteine labeling and MS is that the modiﬁcation of cysteines
with the large hydrophobic maleimide-biotin moiety results in
poor chromatographic, ionisation and fragmentation behavior
compared to normally alkylated peptides. A smaller cysteine
modiﬁcation would permit better identiﬁcation of the peptides
containing the modiﬁed cysteine residues. Similarly, low pH-
mediated separation of antigen and antibody may offer an
advantage for downstream procedures compared to a malei-
mide-PEO2-biotin (MPB)-liganded molecule.
We describe the production of a unique monoclonal anti-
body (mAb), OX133, which recognizes N-ethylmaleimide
(NEM) bound to cysteine residues in proteins. OX133 detects
NEM-modiﬁed proteins on the cell surface, and can be used as
an afﬁnity matrix to purify NEM-modiﬁed proteins from cell
lysates. Crucially, OX133 does not cross react with any other
alkylating agent, making it a highly selective reagent for the
puriﬁcation of NEM-labeled proteins and potentially peptides
for mass spectrometry-based analysis.
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Results
Production of mAb that detect NEM-modiﬁed proteins
HIV-1 surface glycoprotein gp120 contains 9 disulﬁde bonds
that are reported to be labile and susceptible to labeling with
NEM following enzymatic or chemical reduction.15-19 Com-
plete reduction was determined by testing the reducing abilities
of several different reducing conditions followed by labeling the
free cysteine residues generated with Alexa Fluor 633-conju-
gated maleimide and visualization by SDS-PAGE (Fig. 1A).
Compared with the biologically relevant enzyme reductants thi-
oredoxin (TRX) and PDI, reduction by tris(2-carboxyethyl)
phosphine (TCEP) gave a more reproducible degree of labeling
(Fig. 1B), which was complete by 20 minutes of reduction (data
not shown). Accordingly, TCEP was used to prepare a batch of
reduced gp120 for immunization and, following seroconver-
sion, mAb production was completed using standard proce-
dures. Following the initial cloning, mAbs were screened by
ELISA for those that gave strong binding to reduced gp120, but
no binding to unreduced gp120. One mAb, termed OX133, was
cloned by limiting dilution and analyzed in detail.
OX133 recognizes NEM-modiﬁed cysteines in disulﬁde
bonds in multiple proteins
OX133 exhibited the properties expected of a mAb that prefer-
entially recognized reduced gp120, but its speciﬁcity for the
surrounding peptide sequence was unclear. To assess this,
OX133 binding to a variety of non-gp120 proteins that were
unreduced or reduced and alkylated with NEM was tested by
ELISA. As speciﬁcity controls, OX133 failed to react above
background levels with TCEP-reduced b-casein, which does
not contain any cysteine residues. Similarly, minimal labeling
was apparent on a range of proteins, e.g., bovine serum albumin
(BSA), insulin, CD200 and gp120, when they were not chemi-
cally reduced (Fig. 2A). Upon reduction, however, substantial
OX133 mAb binding was observed to all disulﬁde bond-con-
taining targets with an increase in binding of typically more
than 2-fold over the non-reduced form, depending on the num-
ber of labile disulﬁde bonds present. OX133 showed no reactiv-
ity to wells containing protein that had not undergone NEM
treatment, i.e., proteins reduced but not alkylated, or to each
protein treated with the alternative alkylating agent, iodoaceta-
mide (IAA). OX133 is therefore speciﬁc for NEM-labeled pro-
teins, and its speciﬁcity for NEM in a protein-bound form was
further characterized by inhibition ELISA. Capture plates were
prepared using BSA reduced with TCEP and alkylated with
NEM and OX133 binding titrated in the presence of dilutions
of either non-reduced or TCEP-reduced and alkylated BSA in
solution (at 5–0.25 mg ml¡1). As before, OX133 binding was
not affected by the presence of non-reduced competitor in the
mobile phase, whereas a concentration-dependent competition
with the capture target was observed in the presence of free
reduced and alkylated protein (Fig. 2B). Free NEM in the
mobile phase did not alter binding at any concentration tested
(not shown). Thus OX133 is a unique mAb recognizing poly-
peptide resident, NEM-modiﬁed cysteine residues in a
sequence-independent manner. OX133 also bound NEM-mod-
iﬁed gp120 after tryptic digest (data not shown), suggesting no
requirement for full-length protein but no further characteriza-
tion of any minimal peptide length was completed.
OX133 recognizes multiple labile disulﬁde binding sites on
the surface of 2B4 cells following reduction
To determine if OX133 could be used as a tool to recognize
NEM labeling of cysteines in their native environment follow-
ing reduction at the cell surface, the murine 2B4 hybridoma
cell line previously shown to have a large number of reducible
cell surface resident proteins 13 was treated with reducing
reagents and alkylated with NEM, followed by OX133 binding
and detection by ﬂow cytometry. OX133 mAb labeling
increased following treatment with TRX (Fig. 3A - dark gray)
or TCEP (Fig. 3B - dark gray) compared to OX133 binding to
non-reduced cells (Fig. 3A and B - light gray). The median ﬂuo-
rescent intensity (FL1-H) values for 4 replicates revealed that
both TRX and TCEP treatment increased OX133 binding (59
§ 16 and 83 § 27 respectively) when compared to binding to
Figure 1. gp120 contains redox labile disulﬁde bonds which are effectively
reduced by TCEP (A) Maltose binding protein-tagged gp120 from HIV-1 CN54
(1 mg - MW 120 kDa) was incubated for 30 min with TCEP (2.5 mM), TRX (1.25 mg)
or PDI (1 mg) and alkylated using 5 mM Alexa Fluor 633-conjugated maleimide.
Samples were separated by non-reducing SDS-PAGE alongside non-reduced pro-
tein and PDI and TRX enzyme only as controls. (B) The integrated intensity of pro-
tein bands was quantiﬁed using LICOR Odyssey software. Data shown are
representative of 3 separate experiments.
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non-reduced 2B4 cells (17 § 3) with TCEP reduction revealing
more alkylation sites as a result of reducing more labile disul-
ﬁdes (Fig. 3C). OX133 was also coupled to cyanogen bromide-
activated sepharose and used to capture NEM labeled proteins
from 2B4 cell lysates that had been reduced with TCEP and
alkylated with NEM or MPB, as described for Fig. 3A. Precipi-
tated proteins were separated by non-reducing SDS-PAGE and
immunoblots were probed using OX133 followed by an anti-
mouse conjugate. OX133 detected proteins that had been
labeled with NEM, recognizing multiple bands of >100kDa-
<30kDa in the reduced and alkylated sample treated with
NEM, but not in the sample treated with MPB (Fig. 3D). Thus,
the mAb OX133 immunoprecipitates and detects a range of
proteins, facilitating the precipitation of speciﬁcally NEM-
labeled proteins from cell lysates.
Discussion
We describe the production of OX133, a unique mAb that can
selectively detect or purify NEM-labeled cysteine residues in
proteins. OX133 was generated by the immunization of mice
with reduced and NEM-alkylated gp120 as part of a program
to characterize redox intermediates of the gp120 glycoprotein
of HIV. HIV gp120 was an ideal immunogen for the generation
of reduced disulphide bond discerning antibodies as a result of
the 9 disulﬁde bonds within it structure, 2 of which can be
reduced by PDI.15 Reduction of gp120 was achieved by reduc-
ing agents PDI, thioredoxin and TCEP, but maximal gp120
reduction was observed with TCEP. The mAbs generated were
screened for those that distinguished reduced from nonreduced
gp120 protein as evidenced by a strongly increased binding to
NEM-labeled products. OX133 was found to additionally rec-
ognize maleimide labeling of a range of proteins, including
BSA, CD200RLa, gp120 and insulin. Conversely, OX133 did
not bind to non-labeled proteins or those that were alkylated
with iodoacetamide, demonstrating that OX133 speciﬁcally rec-
ognizes NEM bound to the cysteine residue within a polypep-
tide. The observed level of OX133 binding broadly correlated
with the number of labile disulﬁdes present; BSA contains an
undetermined number of labile disulﬁde bonds,15 while 2 of the
3 disulﬁde bonds in bovine insulin are crucial for maintaining
interactions between the A and B chains of the protein and are
known to be reduced by thiol isomerase enzymes in vitro.20,21
CD200RLa, an activatory paired receptor is formed of 2 Ig-like
domains and contains 4 disulﬁde bonds and 1 unpaired cyste-
ine, explaining a low level of OX133 binding to non-reduced
CD200RLa that increased substantially upon TCEP reduc-
tion.22 OX133 showed minor binding to non-reduced gp120
conﬁrming the ﬁnding that 1 free thiol may be present in the
mature folded protein.15 Generally, background binding to
non-reduced samples with no known free Cys was low, but it
should be noted that NEM can modify amines at pH >7 .5,
and higher backgrounds could result. In addition to solution
phase binding, OX133 bound to the murine hybridoma 2B4
cell surface following reduction with either TCEP or thiore-
doxin and, following coupling to cyanogen bromide-activated
sepharose, to reduced and alkylated proteins from these cells.
We conclude that OX133 provides a useful alternative to
ﬂuorescently conjugated maleimide compounds for the
detection of modiﬁed free cysteine residues both at the cell
surface and in the study of isolated proteins. Of direct prac-
tical value, the puriﬁcation of NEM-labeled proteins and
potentially peptides for the preparation of mass spectrome-
try samples may prove superior to the use of biotin-malei-
mide as its use avoids the large biotin moiety and beneﬁts
subsequent processing,13 although we did not measure
directly the relative afﬁnities of NEM modiﬁed targets for
OX133 verses biotin-maleimide. Additionally, OX133 may
prove useful in the study of redox changes associated with
pathological conditions as has been the case for the study
of protein-bound glutathione in atherosclerotic aortic
lesions using a glutathione-dependent antibody.23
Methods and materials
Materials
Dulbecco’s modiﬁed Eagle media, protease-free BSA, b-casein,
insulin, lentil lectin agarose, alkaline phosphatase-conjugated
Figure 2. OX133 recognizes reductive changes in multiple proteins containing
labile disulﬁde bonds (A) Target proteins (b-casein, BSA, insulin, CD200RLa or
gp120 1 mg/mL) were incubated with PBS, NEM (5 mM) or IAA (5 mM) following
reduction with 2.5 mM TCEP for 30 minutes or PBS (non-reduced sample) and
coated onto wells of a Maxisorb microtiter plate. Wells were blocked with 0.5%
(w/v) protease-free BSA in PBS/Tween for 1 hour at room temperature and alky-
lated reduction sites detected by incubation with OX133 antibody (0.5 mg/mL in
PBS-BSA-Tween) for 1 hour at room temperature. Antibody binding to the plate
was determined using anti-mouse alkaline phosphatase conjugate (1:4000) and p-
NPP substrate. (B) OX133 speciﬁcity for protein-bound NEM was measured by inhi-
bition ELISA. BSA was incubated with either PBS or TCEP (2.5 mM) for 20 minutes,
then alkylated with 5 mM NEM for 30 minutes and the unreacted NEM removed.
Reduced and alkylated BSA was immobilized to the plate and OX133 binding
assessed in competition with free BSA or reduced and alkylated BSA. Antibody
binding to the plate was determined using anti-mouse alkaline phosphatase conju-
gate (1:4000) and p-NPP substrate.
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secondary antibodies, p-nitrophenylphosphate substrate
(pNPP), human TRX, rat thioredoxin reductase, cyanogen bro-
mide activated (CNBR) sepharose and NADPH were obtained
from Sigma (Poole, UK). Alexa 633-conjugated maleimide was
from Invitrogen Life Technologies (Paisley, UK) and TCEP
and MPB were from Thermo Fisher Scientiﬁc. Puriﬁed
CD200RLa protein was obtained from Dr Debbie Hatherley
(University of Oxford, UK) and puriﬁed maltose binding pro-
tein (MBP)-gp120 fusion protein was prepared as described.24
Detection of reduced proteins by SDS-PAGE and
ﬂuorescent-labeled maleimide
In the initial screening assays, MBP-gp120 was reduced for
30 minutes by incubation with 2.5 mM TCEP, thioredoxin or
PDI (both 1 mg). Cysteine residues freed by disulﬁde reduction
were labeled by incubation with 5 mM Alexa 633-conjugated
maleimide for 5 minutes. Non-reduced samples were prepared
by immediately alkylating protein treated with phosphate-buff-
ered saline (PBS) only. Proteins were separated alongside
enzyme-only controls by non-reducing SDS-PAGE and visual-
ized using a LICOR scanner and Odyssey software.
Monoclonal antibody production and screening
Puriﬁed MBP-gp120 was reduced using TCEP (2.5 mM) for
20 minutes and alkylated using NEM (5 mM solubilized in
PBS) for 30 minutes. Unbound NEM was removed from pro-
tein preparations by buffer exchange into PBS using multiple
rounds of dilution and ultraﬁltration. Immunizations of Balb/
C mice (50 mg/animal) were performed initially in Freund’s
complete adjuvant with subsequent immunizations using
Freund’s incomplete adjuvant. MAbs were generated using
standard techniques using mouse Sp2/0-Ag14 cells as the
hybridoma partner (Bioserv, Shefﬁeld, UK). MAbs recognizing
NEM-labeled proteins were detected by ELISA using microti-
ter plates (Nunc Maxisorp) coated with 100 mL of 1 mg/mL
non-reduced or TCEP-reduced gp120 (reduced and alkylated
as before) solubilized in 50 mM carbonate-bicarbonate buffer
(pH 9.6). Non-speciﬁc sites were blocked by incubation with
1% (w/v) protease-free BSA for 1 hour at room temperature
and mAbs (100 mL) added for 1 hr with agitation. Antibody
binding was detected using alkaline phosphatase-conjugated
anti-mouse IgG (1:4000) and p-NPP substrate. MAbs that
showed limited reactivity to non-reduced protein and high
reactivity to TCEP-reduced protein were selected for cloning
and further analysis.
Figure 3. OX133 binds to reduced and labeled proteins at the cell surface and after immobilisation to support surfaces. 2B4 cells (1 £ 106) were treated for 30 minutes
with TCEP (2.5 mM), TRX (1.25 ug) or PBS as non-reduced (NR) control (both panels). Washed cells were alkylated with NEM (5 mM) and the labile disulﬁdes revealed
were labeled with OX133 (1:100) for 20 minutes. Binding was detected by an anti-mouse FITC-conjugate (1:200) followed by ﬂow analysis on a FACSCalibur ﬂow cytome-
ter (BD Biosciences). 10,000 gated (live cell) events were recorded in 4 separate experiments: NR (light gray histogram); TCEP (panel (A)) or TRX (panel (B)) reduction
(dark gray histogram). Median ﬂuorescence values for all data revealed that TCEP reduction enhanced NEM labeling of labile disulﬁdes most strongly (p < 0.05) (C). 2B4
cell lysates from TCEP reduced and NEM alkylated samples were precipitated using sepharose-coupled OX133, separated by SDS-PAGE and Western blotted using OX133
antibody (1:1000) and an anti-mouse conjugate (D).
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Detection of NEM-modiﬁed proteins by ELISA
Nunc Maxisorp microtiter plates were coated with protein
(b-casein, BSA, insulin, CD200RLa or gp120, all at 1 mg/mL,
these antigens being non-reduced, TCEP reduced and alkylated
with NEM, IAA or not alkylated) solubilized in 50 mM carbon-
ate-bicarbonate buffer (pH 9.6) overnight at 4C. Wells were
blocked by incubation with 1% (w/v) protease-free BSA in
PBS/Tween for 1 hour at room temperature and alkylated
reduction sites detected through binding of OX133 (0.5 mg/mL
in PBS-BSA-Tween) for 1 hour at room temperature and
detection.
Labile disulﬁde speciﬁcity binding ELISA
OX133 speciﬁcity was measured by inhibition ELISA: BSA was
incubated with either PBS or TCEP (2.5 mM) for 20 minutes
then alkylated with 5 mM NEM for 30 minutes and unreacted
NEM removed by spin dialysis. Reduced and alkylated BSA
and free NEM-treated plates were incubated with OX133
(0.5 mg/mL in PBS-BSA-Tween) for 1 hour at room tempera-
ture and detected as before.
OX133 labeling of 2B4 cells by ﬂow cytometry
The 2B4 murine hybridoma line was cultured in DMEM sup-
plemented with 5% (v/v) fetal bovine serum, 1% (v/v) L-gluta-
mine and 1% (v/v) penicillin-streptomycin and cells grown in
an environment containing 5% CO2. Cells (~106) were harvested
at 95%-100% viability and treated for 30 minutes with TCEP
(2.5 mM), TRX (1.25 mg) or PBS followed by 2 washes in PBS
and alkylation with NEM (5 mM), IAA (5 mM) or MPB
(5 mM). Cells were labeled with OX133 (1:100) for 20 minutes
and anti-mouse FITC-conjugate (1:200), washed and analyzed
on a FACSCalibur ﬂow cytometer (Becton Dickinson). Data for
10,000 events gated on live cells were recorded.
Preparation of OX133 sepharose and immunoprecipitation
CNBr-activated sepharose was prepared by acidifying in 1 mM
HCl. OX133 (1 mg) suspended in coupling buffer (0.1 M
NaHCO3, 0.5 M NaCl, pH 8.3) was rotated with prepared
CNBr sepharose overnight at 4C and unbound antibody
removed by washing with coupling buffer. Residual active
groups on the resin were blocked by incubation with 1 M etha-
nolamine (pH 9) for 2 hours at room temperature. The resin
was washed in the following sequence: TRIS-buffered saline
(25 mM TRIS, 140 mM NaCl, pH7.4), 0.1 M glycine (pH 3.5)
and PBS. 2B4 cells (1 £ 106/mL), reduced and alkylated with
either MPB or NEM as described earlier were lysed in PBS con-
taining 1% (v/v) Triton X-100 in the presence of protease
inhibitors and 5 mM Iodoacetamide and cell debris removed
by centrifugation at 16,000g for 20 minutes. Proteins were then
mixed with 100 ul OX133 sepharose and immunoprecipitated
overnight at 4C. Unbound proteins were removed using multi-
ple detergent washes (PBS with 0.1% (v/v) Triton-X100) and
precipitated proteins analyzed using SDS-PAGE and
immunoblotting.
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